Good
定
Biotech's -3% Session: A Reminder About Binary Risk in Healthcare Investing
The Nasdaq Biotechnology Index fell 3% in a single session. Fulcrum Therapeutics dropped 51%. Abivax ADR declined 44%. To someone unfamiliar with biotech investing, these numbers look like a sector-wi...